Skip to main content
  • English (Ireland)
  • English
  • Greek (Greece)
  • Hungarian
  • Romanian
  • Slovenian
  • Spanish
  • Deutsch
  • Swedish
  • Danish
  • Dutch
  • Estonian
  • Latvian
  • French
  • Norwegian
  • Lithuanian
  • Czech
  • Slovak
  • Bulgarian
  • Portuguese (Portugal)
  • Greek (Cyprus)
  • German (Austria)
  • Dutch (Flemish (Belgium))
  • French (Belgium)
  • German Belgium
  • French (Luxembourg)
  • German Luxembourg
  • Icelandic
  • Croatian
  • Finnish
  • Italian
  • Polish
  • Home
  • SmPC
Paediatrics less 4kg Paediatrics less 4kg
Paediatrics package greater than or equal to 4kg Paediatrics package greater than or equal to 4kg
  • Privacy statement
  • Conditions of use
  • Imprint
  • Report a side effect
  • SmPC

© 2021 Bayer Ltd

This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SmPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA.

PP-XAR-IE-0739-2

Last updated on 10/05/2021

Cookie consent image